Status:

UNKNOWN

Sepsis at Södersjukhuset-Adherence to Treatment Guidelines

Lead Sponsor:

Karolinska Institutet

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Brief Summary

A retrospective single-center study with patients with suspected sepsis admitted to the Emergency Department at Södersjukhuset during a period of two years. The aim is to describe the association betw...

Detailed Description

In this single-center study, patients with suspected sepsis admitted to the Emergency Department at Södersjukhuset during a period of two years will be included. About 11,000 patients will be included...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • • Patients admitted to the Emergency Department at Södersjukhuset with suspicion of sepsis defined as blood cultures taken and intravenous antibiotics of type beta-lactam or aminoglycoside prescribed within 48 hours of admission.
  • Exclusion criteria:
  • • Patients transferred from other hospitals or treatment clinics.

Exclusion

    Key Trial Info

    Start Date :

    March 7 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2022

    Estimated Enrollment :

    11000 Patients enrolled

    Trial Details

    Trial ID

    NCT04055727

    Start Date

    March 7 2019

    End Date

    September 1 2022

    Last Update

    November 12 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Södersjukhuset

    Stockholm, Sweden, 11880